Elite Pharmaceuticals (ELTP) Total Non-Current Liabilities (2011 - 2026)
Elite Pharmaceuticals' Total Non-Current Liabilities came in at $4.4 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 91.7% from $52.89 million a year earlier and down 80.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Total Non-Current Liabilities was $22.02 million, down 29.1% from FY2025.
- Total Non-Current Liabilities carries a five-year compound annual growth rate of 39.1% (FY2021 to FY2026).
- Going back by fiscal year, Total Non-Current Liabilities was $31.03 million in FY2025 (+138.3%), $13.02 million in FY2024 (+217.4%), $4.1 million in FY2023 (+26.9%) and $3.23 million in FY2022 (-23.5%).
- The fiscal Q1 2027 figure represents the lowest quarterly Total Non-Current Liabilities since fiscal Q1 2024.
- Year-over-year, Total Non-Current Liabilities has declined for three consecutive quarters, with growth averaging 120.4% over the last eight quarters.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q3 2023 (growth of 384.5%), and the weakest in fiscal Q1 2027 (a decline of 91.7%).
- Business Quant data shows ELTP's Total Non-Current Liabilities at $22.02 million (Q4 2026), $32.91 million (Q3 2026) and $44.99 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 4.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Mar 31, 2026 | 22.02 Mn |
| Dec 31, 2025 | 32.91 Mn |
| Sep 30, 2025 | 44.99 Mn |
| Jun 30, 2025 | 52.89 Mn |
| Mar 31, 2025 | 31.03 Mn |
| Dec 31, 2024 | 39.62 Mn |
| Sep 30, 2024 | 28.08 Mn |
| Jun 30, 2024 | 15.58 Mn |
| Mar 31, 2024 | 13.02 Mn |
| Dec 31, 2023 | 9.12 Mn |
| Sep 30, 2023 | 6.55 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 15.89 Mn |
| Sep 30, 2022 | 16.31 Mn |
| Mar 31, 2022 | 3.23 Mn |
| Dec 31, 2021 | 3.28 Mn |
| Sep 30, 2021 | 3.82 Mn |
| Jun 30, 2021 | 4.50 Mn |
API Access
Elite Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();